Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety, tolerability and effects of MEDI-563 in adults with asthma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MEDI-563

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 1 | Status: COMPLETED